ConductScience.org, home

Paper39476285

Impact of graft type on outcomes following liver transplantation for primary sclerosing cholangitis.

Kumar S and 2 others. Hepatol Int, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Impact of graft type on outcomes following liver transplantation for primary sclerosing cholangitis. Papers, record 39476285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39476285

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of graft type on outcomes following liver transplantation for primary sclerosing cholangitis.
PubMed
Journal
Hepatol Int
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-11-02
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kumar SShivahttps://orcid.org/0000-0003-3574-0714
2Lin SSonghua
3Schold JDJesse Dhttps://orcid.org/0000-0002-5341-7286

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Liver TransplantationMajor topic
Cholangitis, SclerosingMajor topic
Humans
Male
Female
Middle Aged
Retrospective Studies
Graft Survival
Adult
Living Donors
Registries
Treatment Outcome

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120101749Diagnosis and management of primary sclerosing cholangitis.Hepatology2010https://conductscience.org/library/papers/20101749PubMed
222965893Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death.Liver Transpl2013https://conductscience.org/library/papers/22965893PubMed
327339253Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.Liver Transpl2016https://conductscience.org/library/papers/27339253PubMed
422335632Lack of standardization in exception points for patients with primary sclerosing cholangitis and bacterial cholangitis.Am J Transplant2012https://conductscience.org/library/papers/22335632PubMed
520617395Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database.J Gastrointest Surg2010https://conductscience.org/library/papers/20617395PubMed
620393979Similar liver transplantation survival with selected cardiac death donors and brain death donors.Br J Surg2010https://conductscience.org/library/papers/20393979PubMed
721219581Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry.Am J Transplant2011https://conductscience.org/library/papers/21219581PubMed
832837828The Changing Landscapes in DCD Liver Transplantation.Curr Transplant Rep2020https://conductscience.org/library/papers/32837828PubMed
933196626Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry.Transplantation2021https://conductscience.org/library/papers/33196626PubMed
1025234946Unmet clinical need in autoimmune liver diseases.J Hepatol2015https://conductscience.org/library/papers/25234946PubMed
1125340598Donation after cardiac death liver transplantation in primary sclerosing cholangitis: proceed with caution.Transplantation2015https://conductscience.org/library/papers/25340598PubMed
1217931204Histological recurrence of autoimmune liver diseases after living-donor liver transplantation.Hepatol Res2007https://conductscience.org/library/papers/17931204PubMed
1328288061Impact of Donor Age on Recipient Survival in Adult-to-Adult Living-donor Liver Transplantation.Ann Surg2018https://conductscience.org/library/papers/28288061PubMed
1426438008Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis.Liver Transpl2016https://conductscience.org/library/papers/26438008PubMed
1530811890OPTN/SRTR 2017 Annual Data Report: Liver.Am J Transplant2019https://conductscience.org/library/papers/30811890PubMed
1630639505Survival advantage for patients accepting the offer of a circulatory death liver transplant.J Hepatol2019https://conductscience.org/library/papers/30639505PubMed
1719243003A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.Liver Transpl2009https://conductscience.org/library/papers/19243003PubMed
1821544035Current trends in living donor liver transplantation for primary sclerosing cholangitis.Transplantation2011https://conductscience.org/library/papers/21544035PubMed
1931898414OPTN/SRTR 2018 Annual Data Report: Deceased Organ Donation.Am J Transplant2020https://conductscience.org/library/papers/31898414PubMed
2023481320Scientific Registry of Transplant Recipients: collecting, analyzing, and reporting data on transplantation in the United States.Transplant Rev (Orlando)2013https://conductscience.org/library/papers/23481320PubMed

See all 29 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
41825099Evaluation and management of primary sclerosing cholangitis patients awaiting liver transplantation.JHEP Rep2026https://conductscience.org/library/papers/41825099

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39476285

GET https://conductscience.org/api/papers/v1/39476285/references?page=2